Skip to main content

Table 1 Correlation of KLK12 mRNA expression with clinicopathological variables in patients with triple-negative breast cancer

From: Prognostic value of kallikrein-related peptidase 12 (KLK12) mRNA expression in triple-negative breast cancer patients

Clinical parameters

No. of patients

KLK12a

Negative/Positive

Age

 

p = 0.487

 ≤ 60 years

62

35/27

 > 60 years

54

27/27

Lymph node status

 

p = 0.214

 N0

63

37/26

 N1/N2/N3

53

25/28

Tumor size

 

p = 0.815

 ≤ 20 mm

31

17/14

 > 20 mm

84

44/40

Histological grade

 

p = 0.405

 Grade II

20

9/11

 Grade III

96

53/43

  1. Due to missing values, numbers do not always add up to n = 116
  2. a Categorized into positive- and negative-expressing groups